Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir and Nevirapine in antiretroviral-experienced HIV patients
NCT00004581Phase 3Completed
- Sponsor
- Abbott Laboratories
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
Phase 3, randomised, open-label trial of lopinavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Abbott Laboratories. Status: completed.
02
Drugs
lopinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004581.